Cancer of Unknown Primary Site Completed Phase 2 Trials for Capecitabine (DB01101)

Indication	Status	Phase
DBCOND0089665 (Cancer of Unknown Primary Site)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01845337	Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine	Treatment	Capecitabine (DB01101) Gimeracil (DB09257) Oteracil (DB03209) Tegafur (DB09256)